An evaluation of gentamicin susceptibility of Neisseria gonorrhoeae isolates in Europe

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 3, 2011, Pages 592-595

  Chisholm, Stephanie A ^a   Quaye, Nerteley ^a   Cole, Michelle J ^a   Fredlund, Hans ^b   Hoffmann, Steen ^c   Jensen, Jørgen Skov ^c   van de Laar, Marita J ^d   Unemo, Magnus ^b   Ison, Catherine A ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^c STATENS SERUM INSTITUT   (Denmark)

^d EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

Author keywords

Agar dilution; Antimicrobial resistance; Etest; Sentinel surveillance

Indexed keywords

GENTAMICIN;

AGAR DILUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; EPSILOMETER TEST; EUROPE; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NONHUMAN;

ADOLESCENT; ANTI-BACTERIAL AGENTS; EUROPEAN UNION; GENTAMICINS; GONORRHEA; HUMANS; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE; YOUNG ADULT;

EID: 79951520585     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq476     Document Type: Article

References (14)

1. Lewis DA. The Gonococcus fights back: is this time a knock out? Sex Transm Infect 2010; 86: 415-21.
2. Bignell C. 2009 European (IUSTI/WHO) guideline on the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS 2009; 20: 453-7.
3. Lule G, Behets FM, Hoffman IF et al. STD/HIV control in Malawi and the search for affordable and effective urethritis therapy: a first field evaluation. Genitourin Med 1994; 70: 384-8.
4. Tan NJ, Rajan VS, Pang R et al. Gentamicin in the treatment of infections due to penicillinase-producing gonococci. Br J Vener Dis 1980; 56: 394-6.
5. Hira SK, Attili VR, Kamanga J et al. Efficacy of gentamicin and kanamycin in the treatment of uncomplicated gonococcal urethritis in Zambia. Sex Transm Dis 1985; 12: 52-4.
6. Brown LB, Krysiak R, Kamanga G et al. Neisseria gonorrhoeae antimicrobial susceptibility in Lilongwe, Malawi, 2007. Sex Transm Dis 2010; 37: 169-72.
7. Daly CC, Hoffman I, Hobbs M et al. Development of an antimicrobial susceptibility surveillance system for Neisseria gonorrhoeae in Malawi: comparison of methods. J Clin Microbiol 1997; 35: 2985-8.
8. Cole MJ, Chisholm SA, Hoffmann S et al. European surveillance of antimicrobial resistance in Neisseria gonorrhoeae. Sex Transm Infect 2010; 86: 427-32.
9. Unemo M, Fasth O, Fredlund H et al. Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes. J Antimicrob Chemother 2009; 63: 1142-51.
10. GRASP Steering Group. The Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) Year 2008 Report. London: Health Protection Agency, 2009.
11. Lesmana M, Lebron CI, Taslim D et al. In vitro antibiotic susceptibility of Neisseria gonorrhoeae in Jakarta, Indonesia. Antimicrob Agents Chemother 2001; 45: 359-62.
12. Joesoef MR, Knapp JS, Idajadi A et al. Antimicrobial susceptibilities of Neisseria gonorrhoeae strains isolated in Surabaya, Indonesia. Antimicrob Agents Chemother 1994; 38: 2530-3.
13. Sutrisna A, Soebjakto O, Wignall FS et al. Increasing resistance to ciprofloxacin and other antibiotics in Neisseria gonorrhoeae from East Java and Papua, Indonesia, in 2004-implications for treatment. Int J STD AIDS 2006; 17: 810-2.
14. Rice RJ, Knapp JS. Susceptibility of Neisseria gonorrhoeae associated with pelvic inflammatory disease to cefoxitin, ceftriaxone, clindamycin, gentamicin, doxycycline, azithromycin, and other antimicrobial agents. Antimicrob Agents Chemother 1994; 38: 1688-91.